Eden Research (LON:EDEN) Stock Jumps 10.5% – Still a Buy?

Eden Research plc (LON:EDEN)’s share price traded up 10.5% during trading on Friday. The stock traded as high as GBX 3.90 and last traded at GBX 3.43. Approximately 6,729,103 shares traded hands during mid-day trading, an increase of 988% from the average daily volume of 618,734 shares. The stock had previously closed at GBX 3.10.

Eden Research Stock Up 10.5%

The company has a current ratio of 1.95, a quick ratio of 2.42 and a debt-to-equity ratio of 5.41. The company has a 50-day simple moving average of GBX 2.53 and a 200 day simple moving average of GBX 3.01. The company has a market cap of £27.52 million, a P/E ratio of -7.73 and a beta of 1.55.

Eden Research (LON:EDEN) last released its earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share for the quarter. Eden Research had a negative return on equity of 16.16% and a negative net margin of 50.43%. On average, equities analysts anticipate that Eden Research plc will post -66.00 EPS for the current year.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.